US Equity

Take advantage of elevated option premiums to gain long exposure to biotech.
We can see encouraging signs like the bullish divergence between the price action and the momentum indicator on a weekly scale.
Buying undervalued assets almost always requires accepting a period of discomfort.
Things seem bright for Tutor Perini and Great Lakes Dredge & Dock.
I'm cancelling this trade. As a rule, I give trades two days to set up, or I axe them.
A close under $33 today would be a big red flag.
Differing results and dealings with Nelson Peltz produce a CEO winner and loser.

Breaking Up With Celgene Real Money Pro($)

Two major red flags warn against a long-term relationship with this biotech.
With such a commanding lead in the sequencing business the stock can't stay down for long.
LXK checks all my boxes: momentum, trend, price action, volume and volatility.

Columnist Conversations

FANG and Apple are both acting punk. Will they lead the market lower or will a broader market rally bring them...
Apple continues to look sluggish following its ugly 3% drop on Sept. 29th(
Early gains go "poof" as volatility continues to be at heightened levels in the market compared to first half ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.